Federico Mingozzi

2.2k total citations
31 papers, 1.5k citations indexed

About

Federico Mingozzi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Federico Mingozzi has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 16 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Federico Mingozzi's work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (11 papers) and Lysosomal Storage Disorders Research (11 papers). Federico Mingozzi is often cited by papers focused on Virus-based gene therapy research (21 papers), CAR-T cell therapy research (11 papers) and Lysosomal Storage Disorders Research (11 papers). Federico Mingozzi collaborates with scholars based in United States, France and Spain. Federico Mingozzi's co-authors include Katherine A. High, Daniel J. Hui, Etiena Basner‐Tschakarjan, Christian Hinderer, Roland W. Herzog, P. Véron, Virginia Haurigot, Gregory M. Podsakoff, Florence Boisgérault and Sara Marcó and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Federico Mingozzi

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Mingozzi United States 19 1.0k 918 391 323 308 31 1.5k
Christian Hinderer United States 21 1.4k 1.4× 1.4k 1.5× 302 0.8× 411 1.3× 244 0.8× 32 2.3k
Xavier M. Anguela United States 17 1.3k 1.3× 1.7k 1.8× 476 1.2× 199 0.6× 137 0.4× 31 2.2k
Delila Serra United States 21 676 0.7× 753 0.8× 354 0.9× 166 0.5× 126 0.4× 30 1.5k
Scott Loiler United States 13 781 0.8× 722 0.8× 140 0.4× 99 0.3× 160 0.5× 20 1.2k
Giridhara R. Jayandharan India 27 1.2k 1.2× 1.6k 1.7× 232 0.6× 60 0.2× 174 0.6× 83 2.3k
Allison M. Keeler United States 16 442 0.4× 618 0.7× 181 0.5× 169 0.5× 89 0.3× 31 1.0k
Helena Costa Verdera France 7 535 0.5× 917 1.0× 219 0.6× 81 0.3× 100 0.3× 10 1.2k
Hideki Hanawa Japan 20 1.2k 1.2× 1.3k 1.4× 367 0.9× 106 0.3× 130 0.4× 38 1.9k
Caroline Le Guiner France 20 657 0.7× 1.3k 1.4× 119 0.3× 123 0.4× 82 0.3× 47 1.6k
Sandeep K. Tripathy United States 13 820 0.8× 919 1.0× 256 0.7× 66 0.2× 156 0.5× 20 1.6k

Countries citing papers authored by Federico Mingozzi

Since Specialization
Citations

This map shows the geographic impact of Federico Mingozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Mingozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Mingozzi more than expected).

Fields of papers citing papers by Federico Mingozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Mingozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Mingozzi. The network helps show where Federico Mingozzi may publish in the future.

Co-authorship network of co-authors of Federico Mingozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Mingozzi. A scholar is included among the top collaborators of Federico Mingozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Mingozzi. Federico Mingozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marais, Thibaut, Elena Barbon, Maria Grazia Biferi, et al.. (2022). Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice. SHILAP Revista de lepidopterología. 4. 785698–785698. 16 indexed citations
2.
Colella, Pasqualina, Manuel J. Gómez, Maria Grazia Biferi, et al.. (2020). Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects. EBioMedicine. 61. 103052–103052. 18 indexed citations
3.
Colella, Pasqualina & Federico Mingozzi. (2019). Gene Therapy for Pompe Disease: The Time is now. Human Gene Therapy. 30(10). 1245–1262. 18 indexed citations
4.
Poupiot, Jérôme, Helena Costa Verdera, Romain Hardet, et al.. (2019). Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy — Methods & Clinical Development. 15. 83–100. 19 indexed citations
5.
Kuranda, Klaudia, Christian Leborgne, Romain Hardet, et al.. (2018). Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation. 128(12). 5267–5279. 78 indexed citations
6.
7.
Han, Sang-oh, Giuseppe Ronzitti, Christian Leborgne, et al.. (2017). Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction. Molecular Therapy — Methods & Clinical Development. 4. 126–136. 60 indexed citations
8.
Colella, Pasqualina, Francesco Puzzo, Maria Grazia Biferi, et al.. (2017). Whole-body rescue of Pompe disease with AAV liver delivery of engineered secretable GAA transgenes. Neuromuscular Disorders. 27. S246–S246. 1 indexed citations
9.
Boisgérault, Florence & Federico Mingozzi. (2015). The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer. Current Gene Therapy. 15(4). 381–394. 40 indexed citations
10.
Jeanson-Leh, Laurence, et al.. (2015). Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System. Human Gene Therapy Methods. 26(2). 45–53. 86 indexed citations
11.
Mauhin, Wladimir, Olivier Lidove, Elisa Masat, et al.. (2015). Innate and Adaptive Immune Response in Fabry Disease. JIMD Reports. 22. 1–10. 68 indexed citations
12.
Hui, Daniel J., Gregory M. Podsakoff, Gary C. Pien, et al.. (2015). AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes. Molecular Therapy — Methods & Clinical Development. 2. 15029–15029. 67 indexed citations
13.
Allenbach, Yves, Wahiba Chaara, Michèlle Rosenzwajg, et al.. (2014). Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis. PLoS ONE. 9(3). e88788–e88788. 61 indexed citations
14.
Haurigot, Virginia, Sara Marcó, Albert Ribera, et al.. (2013). Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. Journal of Clinical Investigation. 123(8). 3254–3271. 176 indexed citations
15.
Groot, Anne S. De, Leslie P. Cousens, Federico Mingozzi, & William J. Martin. (2013). Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?. SHILAP Revista de lepidopterología. 2013. 1–6. 21 indexed citations
16.
Hui, Daniel J., Etiena Basner‐Tschakarjan, Robert J. Davidson, et al.. (2013). Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Molecular Therapy. 21(9). 1727–1737. 39 indexed citations
17.
Gil-Fariña, Irene, Marianna Di Scala, Lucía Vanrell, et al.. (2013). IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression. PLoS ONE. 8(7). e67748–e67748. 18 indexed citations
18.
Cousens, Leslie P., Federico Mingozzi, Sander van der Marel, et al.. (2012). Teaching tolerance. Human Vaccines & Immunotherapeutics. 8(10). 1459–1464. 15 indexed citations
19.
Sabatino, Denise E., Federico Mingozzi, Daniel J. Hui, et al.. (2005). Identification of mouse AAV capsid-specific CD8+ T cell epitopes. Molecular Therapy. 12(6). 1023–1033. 76 indexed citations
20.
Fields, Paul, Valder R. Arruda, Elina Armstrong, et al.. (2001). Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9. Molecular Therapy. 4(3). 201–210. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Hinderer Breakdown of academic impact, for papers by Xavier M. Anguela Breakdown of academic impact, for papers by Delila Serra Breakdown of academic impact, for papers by Scott Loiler Breakdown of academic impact, for papers by Giridhara R. Jayandharan Breakdown of academic impact, for papers by Allison M. Keeler Breakdown of academic impact, for papers by Helena Costa Verdera Breakdown of academic impact, for papers by Hideki Hanawa Breakdown of academic impact, for papers by Caroline Le Guiner Breakdown of academic impact, for papers by Sandeep K. Tripathy
Rankless by CCL
2026